Astal Laboratories Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Astal Laboratories Ltd is ₹ 63 as of 04 May 11:02 . The P/E Ratio of Astal Laboratories Ltd is 0 as of March 2021 .The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2021 . The Market Cap of Astal Laboratories Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 5.48 crore as of March 2021 . The revenue of Astal Laboratories Ltd for the Dec '25 is ₹ 52.27 crore as compare to the Sep '25 revenue of ₹ 37.55 crore. This represent the growth of 39.2% The revenue of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 48.4 crore as compare to the Sep '25 revenue of ₹ 36.39 crore. This represent the growth of 33% The ebitda of Astal Laboratories Ltd for the Dec '25 is ₹ 3.59 crore as compare to the Sep '25 ebitda of ₹ 3.9 crore. This represent the decline of -7.95% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 1.31 crore as compare to the Sep '25 ebitda of ₹ 0.73 crore. This represent the growth of 79.45% The net profit of Astal Laboratories Ltd changed from ₹ 1.69 crore to ₹ 2.36 crore over 7 quarters. This represents a CAGR of 21.02% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ -0.35 crore to ₹ 1 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Astal Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Astal Laboratories Ltd

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited.
The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'.
Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024.
The Company is now a subsidiary of Aceso Research Labs LLP. The Company was promoted by the Kanpur based business house of Parasrampurias.
The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc. During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation.

About Novelix Pharmaceuticals Ltd

Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

FAQs for the comparison of Astal Laboratories Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Astal Laboratories Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Astal Laboratories Ltd is 262 Cr while Market cap of Novelix Pharmaceuticals Ltd is 58 Cr

What are the key factors driving the stock performance of Astal Laboratories Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Astal Laboratories Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astal Laboratories Ltd and Novelix Pharmaceuticals Ltd?

As of May 4, 2026, the Astal Laboratories Ltd stock price is INR ₹62.13. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹40.5.

How do dividend payouts of Astal Laboratories Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astal Laboratories Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.